choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Brilinta

Brilinta Newsletter
  • AstraZeneca’s earnings surprise investors as cancer drugs fuel growth 25 Apr 2024 19:24 GMT

    … cardiovascular drugs, which include the diabetes pill Farxiga and blood thinner Brilinta, … Two, Gracell Biotechnologies and Fusion Pharmaceuticals, are developing medicines in areas where … radioligand therapies. Upcoming clinical trial results are mostly in …

  • AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance 25 Apr 2024 13:38 GMT

    … in Alliance Revenue from partnered medicines. The company’s adjusted EPADS … higher marketing spend for new drug launches. AstraZeneca’s top … 12 billion. Top-selling cancer drugs were Tagrisso and Imfinzi, … up 24% (28% at CER), Brilinta decreased 3% (1% at CER …

  • Lumosa Therapeutics launches two Phase II trials for stroke candidate 05 Feb 2024 14:42 GMT

    trials. The Lumosa 203 study is a two-part trial evaluating LT3001 drug … aims to extend the treatment window to 24 hours … -half hour window US FDA-approved drug, tissue plasminogen activator … drugs for AIS with the main candidates being AstraZeneca’s Brilinta

  • Vascepa interactions: Alcohol, medications, and other factors 02 Feb 2024 13:17 GMT

    … (Brilinta) vorapaxar (Zontivity) Steps you or your doctor may … treatment with Vascepa, talk with your doctor. Vascepa and vaccines … been enough clinical trials to determine whether … doctor or another healthcare professional before taking any medication. The drug

  • CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation 28 Dec 2023 12:00 GMT

    DrugSorb®-ATR to reduce perioperative bleeding in 140 enrolled patients on ticagrelor (Brilinta … Efthymios N. Deliargyris, Chief Medical Officer of CytoSorbents, stated, … more effective treatment of life-threatening … -T clinical trial results and our …

  • Brilinta and cost 07 Nov 2023 13:58 GMT

    … and Drug Administration (FDA) to reduce the risk of: As with all medications … asked questions about drug cost and Brilinta. Is Brilinta covered by Medicare? It may … and your doctor will discuss Brilinta in regard to your treatment. The insurance …

  • AstraZeneca stays in GLP-1 drug race with new deal 09 Nov 2023 22:50 GMT

    … therapy from China-based biotech Eccogene that’s in … Street analysts and even big pharmaceutical company CEOs like Pfizer’ … diabetes treatment Mounjaro, is catching up quickly. On Wednesday that drug … by Farxiga and blood thinner Brilinta, with sales of $4 …

  • What medications might a doctor prescribe after a heart attack? 10 Oct 2023 11:41 GMT

    … stroke. The most common antiplatelet drug doctors prescribe is aspirin. According … prasugrel (Effient) clopidogrel (Plavix) ticagrelor (Brilinta) Antiplatelets tend to come in … statins. After a heart attack, doctors usually prescribe more than one medication

  • 2018 First Generic Drug Approvals 14 Sep 2023 00:55 GMT

    … , 90 mg  Watson Laboratories, Inc.  Brilinta (Ticagrelor) Tablets, 60 mg, 90 … Injection USP, 100 grams Samson Medical Technologies, L.L.C. Maxipime … alternate treatments are inadequate 17  208342 Miglustat Capsules, 100 mg  Amerigen Pharmaceuticals

  • CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial 15 Aug 2023 06:38 GMT

    … a leader in the treatment of life-threatening … blood thinner, ticagrelor (Brilinta®, AstraZeneca) in patients … FDA Breakthrough Device, DrugSorb-ATR. Dr. Efthymios N. Deliargyris, Chief Medical … star-t-pivotal-trial-301899656.html SOURCE CytoSorbents …

Satisfied with the content?

Continue to create your account.